Literature DB >> 22783439

Analysis of prognostic risk factors and treatment of parotid cancer.

Jinbiao Shang1, Yingjie Wu, Wendong Wang, Kejing Wang, Minghua Ge.   

Abstract

The aim of this study was to investigate the prognostic factors and therapeutic efficacy of parotid cancer (PC). A total of 135 patients with PC who received surgical treatment were recruited between January 1985 and January 2000. There were 47 patients with poorly differentiated PC and 88 with well-differentiated PC. In addition, PC of stage I, II, III and IV were found in 25, 47, 45 and 18 patients, respectively. Elective and therapeutic neck dissection was carried out in 46 and 39 patients, respectively, and 58 patients received post-operative radiotherapy. The Kaplan-Meier method was employed for survival analysis. The 5- and 10-year survival rates were 74.0 and 56.4%, respectively. A significant difference in the survival rates was observed between patients with poorly differentiated PC and those with well-differentiated PC (χ(2)=5.72, P=0.016). Cox regression model analysis revealed that age, stage of PC, pathological grade of PC and post-operative radiotherapy were independent prognostic factors of PC. Early diagnosis, early treatment and post-operative radiotherapy may increase the survival rate of PC patients. Patients with PC should therefore receive neck lymph node dissection, the extent of which depends on the pathological grade of PC.

Entities:  

Year:  2012        PMID: 22783439      PMCID: PMC3392587          DOI: 10.3892/ol.2012.668

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  13 in total

1.  Postoperative radiation therapy for T1 and T2 primary parotid carcinoma: is it useful?

Authors:  Peter Zbären; Michel Nuyens; Marco Caversaccio; Richard Greiner; Edouard Stauffer
Journal:  Otolaryngol Head Neck Surg       Date:  2006-07       Impact factor: 3.497

2.  Risk factors for distant metastases from carcinoma of the parotid gland.

Authors:  O Gallo; A Franchi; G V Bottai; I Fini-Storchi; G Tesi; V Boddi
Journal:  Cancer       Date:  1997-09-01       Impact factor: 6.860

3.  Treatment of malignant neoplasms of the parotid gland.

Authors:  M Magnano; C F gervasio; L Cravero; G Machetta; W Lerda; G Beltramo; R Orecchia; R Ragona; M Bussi
Journal:  Otolaryngol Head Neck Surg       Date:  1999-11       Impact factor: 3.497

4.  Clinical prognostic factors in malignant parotid gland tumors.

Authors:  Roberto A Lima; Marcos R Tavares; Fernando L Dias; Jacob Kligerman; Marilene F Nascimento; Mauro M Barbosa; Claudio R Cernea; Jose R Soares; Izabella C Santos; Scheylla Salviano
Journal:  Otolaryngol Head Neck Surg       Date:  2005-11       Impact factor: 3.497

5.  Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas.

Authors:  I Régis De Brito Santos; L P Kowalski; V Cavalcante De Araujo; A Flávia Logullo; J Magrin
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-01

6.  Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes.

Authors:  Surjeet Pohar; Hiram Gay; Paula Rosenbaum; Darren Klish; Jeffrey Bogart; Robert Sagerman; Jack Hsu; Robert Kellman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-01-01       Impact factor: 7.038

7.  Parotid surgery in patients over seventy-five years old.

Authors:  A Croce; L D'Agostino; A Moretti; A Augurio
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-10       Impact factor: 2.124

8.  Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis.

Authors:  D Pedersen; J Overgaard; H Søgaard; O Elbrønd; M Overgaard
Journal:  Laryngoscope       Date:  1992-09       Impact factor: 3.325

9.  The indications for elective treatment of the neck in cancer of the major salivary glands.

Authors:  J G Armstrong; L B Harrison; H T Thaler; H Friedlander-Klar; D E Fass; M J Zelefsky; J P Shah; E W Strong; R H Spiro
Journal:  Cancer       Date:  1992-02-01       Impact factor: 6.860

10.  Clinico-pathological and treatment-related factors influencing survival in parotid cancer.

Authors:  A G Renehan; E N Gleave; N J Slevin; M McGurk
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

View more
  2 in total

1.  A retrospective study of parotid gland tumors at a single institution.

Authors:  Shiori Suzuki; Nobuyuki Bandoh; Takashi Goto; Akinobu Kubota; Akihiro Uemura; Michihisa Kono; Ryosuke Sato; Ryuhei Takeda; Shota Sakaue; Tomomi Yamaguchi-Isochi; Hiroshi Nishihara; Hidehiro Takei; Yasuaki Harabuchi
Journal:  Oncol Lett       Date:  2022-05-13       Impact factor: 3.111

2.  Prognostic Value of the Lymphocyte-to-Monocyte Ratio in Patients with Parotid Gland Carcinoma.

Authors:  Takuya Mikoshiba; Hiroyuki Ozawa; Yoshihiro Watanabe; Mariko Sekimizu; Shin Saito; Keisuke Yoshihama; Shintaro Nakamura; Yorihisa Imanishi; Kaori Kameyama; Kaoru Ogawa
Journal:  Laryngoscope       Date:  2020-07-16       Impact factor: 3.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.